Co-localisation analysis showed evidence of a shared causal variant for type 2 diabetes liability and eight outcomes at the GIP gene, and six outcomes at the GIPR gene (PP > 0.8, ESM Table 1). This evidence concerns the gene GIPR and type 2 diabetes mellitus.